Literature DB >> 18484708

Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction.

Jillian R Gunther, Terry W Moore, Margaret L Collins, John A Katzenellenbogen.   

Abstract

We report here on the design, synthesis, and evaluation of small molecule inhibitors of the interaction between a steroid receptor coactivator and estrogen receptor alpha. These inhibitors are based upon an amphipathic benzene scaffold whose hydrophobic face mimics the leucine-rich alpha-helical consensus sequence on the steroid receptor coactivators that interacts with a shallow groove on estrogen receptor alpha. Several of these molecules are among the most potent inhibitors of this interaction described to date and are active at low micromolar concentrations in both in vitro models of estrogen receptor action and in cell-based assays of estrogen receptor-mediated coactivator interaction and transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484708      PMCID: PMC2427189          DOI: 10.1021/cb800056r

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  19 in total

1.  Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.

Authors:  P G Martini; R Delage-Mourroux; D M Kraichely; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 2.  Emerging classes of protein-protein interaction inhibitors and new tools for their development.

Authors:  Len Pagliaro; Jakob Felding; Karine Audouze; Søren Jensby Nielsen; Robert B Terry; Christian Krog-Jensen; Steven Butcher
Journal:  Curr Opin Chem Biol       Date:  2004-08       Impact factor: 8.822

Review 3.  Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.

Authors:  Rachel Schiff; Suleiman A Massarweh; Jiang Shou; Lavina Bharwani; Grazia Arpino; Mothaffar Rimawi; C Kent Osborne
Journal:  Cancer Chemother Pharmacol       Date:  2005-11       Impact factor: 3.333

Review 4.  Strategies for targeting protein-protein interactions with synthetic agents.

Authors:  Hang Yin; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2005-07-04       Impact factor: 15.336

5.  Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides.

Authors:  Jorge Becerril; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

6.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

7.  Peptide antagonists of the human estrogen receptor.

Authors:  J D Norris; L A Paige; D J Christensen; C Y Chang; M R Huacani; D Fan; P T Hamilton; D M Fowlkes; D P McDonnell
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

8.  The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

Authors:  A K Shiau; D Barstad; P M Loria; L Cheng; P J Kushner; D A Agard; G L Greene
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  Bicyclo[2.2.2]octanes: close structural mimics of the nuclear receptor-binding motif of steroid receptor coactivators.

Authors:  Hai-Bing Zhou; Margaret L Collins; Jillian R Gunther; John S Comninos; John A Katzenellenbogen
Journal:  Bioorg Med Chem Lett       Date:  2007-05-23       Impact factor: 2.823

10.  Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.

Authors:  J Sun; M J Meyers; B E Fink; R Rajendran; J A Katzenellenbogen; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1999-02       Impact factor: 4.736

View more
  26 in total

Review 1.  Small molecule inhibitors as probes for estrogen and androgen receptor action.

Authors:  David J Shapiro; Chengjian Mao; Milu T Cherian
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

2.  A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

Authors:  Nicole M Kretzer; Milu T Cherian; Chengjian Mao; Irene O Aninye; Philip D Reynolds; Rachel Schiff; Paul J Hergenrother; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  Synthesis of a tetrasubstituted tetrahydronaphthalene scaffold for α-helix mimicry via a MgBr2-catalyzed Friedel-Crafts epoxide cycloalkylation.

Authors:  Devan Naduthambi; Santosh Bhor; Michael B Elbaum; Neal J Zondlo
Journal:  Org Lett       Date:  2013-09-09       Impact factor: 6.005

4.  Estrogen receptor alpha/co-activator interaction assay: TR-FRET.

Authors:  Terry W Moore; Jillian R Gunther; John A Katzenellenbogen
Journal:  Methods Mol Biol       Date:  2015

5.  A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction.

Authors:  Thomas E Speltz; Jeanne M Danes; Joshua D Stender; Jonna Frasor; Terry W Moore
Journal:  ACS Chem Biol       Date:  2018-01-24       Impact factor: 5.100

6.  Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.

Authors:  Anna B Williams; Patrick T Weiser; Robert N Hanson; Jillian R Gunther; John A Katzenellenbogen
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

7.  Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors.

Authors:  Jillian R Gunther; Alexander A Parent; John A Katzenellenbogen
Journal:  ACS Chem Biol       Date:  2009-06-19       Impact factor: 5.100

Review 8.  Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).

Authors:  Terry W Moore; Christopher G Mayne; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-20

9.  Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding.

Authors:  Alexander A Parent; Jillian R Gunther; John A Katzenellenbogen
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

10.  Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor.

Authors:  Min Shan; Kathryn E Carlson; Alexander Bujotzek; Anja Wellner; Ronald Gust; Marcus Weber; John A Katzenellenbogen; Rainer Haag
Journal:  ACS Chem Biol       Date:  2013-01-30       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.